![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 14, 13375-13382, April 2, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
s- and G
i-coupled Receptors
i-COUPLED RECEPTOR BY INFLUENCING PROCESSING OF G
i*


¶
||
From the
Department of Pharmacology and Experimental Therapeutics, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112 and the ¶Pennington Biomedical Research Center, Baton Rouge, Louisiana 70808
AGS3-LONG and AGS3-SHORT contain G-protein regulatory motifs that interact with and stabilize the GDP-bound conformation of G
i > G
o. AGS3 and related proteins may influence signal strength or duration as well as the adaptation of the signaling system associated with sustained stimulation. To address these issues, we determined the effect of AGS3 on the integration of stimulatory (G
s-mediated vasoactive intestinal peptide receptor) and inhibitory (G
i-mediated
2-adrenergic receptor (
2-AR)) signals to adenylyl cyclase in Chinese hamster ovary cells. AGS3-SHORT and AGS3-LONG did not alter the VIP-induced increase in cAMP or the inhibitory effect of
2-AR activation. System adaptation was addressed by determining the influence of AGS3 on the sensitization of adenylyl cyclase that occurs following prolonged activation of a G
i-coupled receptor. Incubation of cells with the
2-AR agonist UK14304 (1 µM) for 18 h resulted in a
1.8-fold increase in the vasoactive intestinal peptide-induced activation of adenylyl cyclase, and this was associated with a decrease in membrane-associated G
i3. Both effects were blocked by AGS3-SHORT. AGS3-SHORT also decreased the rate of G
i3 decay. A mutant AGS3-SHORT incapable of binding G-protein was inactive. These data suggest that AGS3 and perhaps other G-protein regulatory motif-containing proteins increase the stability of G
i in the membrane, which influences the adaptation of the cell to prolonged activation of G
i-coupled receptors.
Received for publication, November 19, 2003 , and in revised form, January 12, 2004.
* This work was supported in part by Grants NS24821 and MH55391 from the National Institutes of Health (to S. M. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Supported in part by the Mochida Memorial Foundation for Medical and Pharmaceutical Research.
|| Supported by the David R. Bethune/Lederle Laboratories Professorship in Pharmacology and a Research Scholar Award from Yamanouchi Pharmaceutical Company, Ltd. To whom correspondence should be addressed: Dept. of Pharmacology, Louisiana State University Health Sciences Ctr., 1901 Perdido St., New Orleans, LA 70112. Tel.: 504-568-4740; E-mail: slanie{at}lsuhsc.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. M. Filipeanu, F. Zhou, M. L. Lam, K. E. Kerut, W. C. Claycomb, and G. Wu Enhancement of the Recycling and Activation of beta-Adrenergic Receptor by Rab4 GTPase in Cardiac Myocytes J. Biol. Chem., April 21, 2006; 281(16): 11097 - 11103. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Mouledous, J. Neasta, S. Uttenweiler-Joseph, A. Stella, M. Matondo, M. Corbani, B. Monsarrat, and J.-C. Meunier Long-Term Morphine Treatment Enhances Proteasome-Dependent Degradation of G{beta} in Human Neuroblastoma SH-SY5Y Cells: Correlation with Onset of Adenylate Cyclase Sensitization Mol. Pharmacol., August 1, 2005; 68(2): 467 - 476. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |